Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.81 +0.01 (+1.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Price to Sales (2021 - 2026)

Updated

Rani Therapeutics Holdings' (RANI) Price to Sales was 29.17 for Q2 2026, up 8.6% from 26.86 a year earlier but down 30.6% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Price to Sales (2021 - 2026) Analysis & Trends

For FY2025, Price to Sales at Rani Therapeutics Holdings was 100.52, up 31.4% from FY2024.

  • By year, Price to Sales came in at 76.50 in FY2024 and 323.01 in FY2021.
  • Five-year quarterly Price to Sales spans a low of 26.86 in Q2 2025 and a high of 323.01 in Q4 2021.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 42.03 (Q1 2026), 100.52 (Q4 2025) and 29.96 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Rani Therapeutics Holdings 151.61 Mn 160.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.17
Mar 31, 2026 42.03
Dec 31, 2025 100.52
Sep 30, 2025 29.96
Jun 30, 2025 26.86
Mar 31, 2025 60.42
Dec 31, 2024 76.50
Jun 30, 2022 258.95
Dec 31, 2021 323.01
Sep 30, 2021 298.33
API Access

Rani Therapeutics Holdings Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=RANI&period=max&api_key=YOUR_API_KEY